The price of BioAffinity Technologies Inc (NASDAQ: BIAF) closed at $2.03 in the last session, up 32.68% from day before closing price of $1.53. In other words, the price has increased by $+0.5000 from its previous closing price. On the day, 1053093 shares were traded.
Ratios:
We take a closer look at BIAF’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.06 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIAF now has a Market Capitalization of 17.03M and an Enterprise Value of 14.21M. For the stock, the TTM Price-to-Sale (P/S) ratio is 58.49 while its Price-to-Book (P/B) ratio in mrq is 2.68. Its current Enterprise Value per Revenue stands at 44.20 whereas that against EBITDA is -2.03.
Stock Price History:
Over the past 52 weeks, BIAF has reached a high of $3.62, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is 1.6525, while the 200-Day Moving Average is calculated to be 1.6180.
Shares Statistics:
According to the various share statistics, BIAF traded on average about 123.16K shares per day over the past 3-months and 648.27k shares per day over the past 10 days. A total of 8.38M shares are outstanding, with a floating share count of 3.55M. Insiders hold about 61.47% of the company’s shares, while institutions hold 1.69% stake in the company. Shares short for BIAF as of Feb 15, 2024 were 9.65k with a Short Ratio of 0.08, compared to 14.18k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.10% and a Short% of Float of 0.19%.
Earnings Estimates
The company has 0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
